Yorktown Management & Research CO Inc Gilead Sciences, Inc. Transaction History

Yorktown Management & Research CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $4.38 Million - $4.9 Million	-70,000 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $2.14 Million - $2.37 Million	30,000 Added 75.0%	70,000 $5.41 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $1.38 Million - $1.69 Million	19,000 Added 90.48%	40,000 $3.02 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $1.49 Million - $1.75 Million	21,000	21,000 $1.5 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

Stay updated on Yorktown Management & Research CO Inc with notifications on news.